FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2909210318> ?p ?o ?g. }

• W2909210318 endingPage "429" @default.
• W2909210318 startingPage "429" @default.
• W2909210318 abstract "Malignant mesothelioma (MMe) is a cancer with poor prognosis and resistance to standard treatments. Recent reports have highlighted the role of the BRCA1 associated protein 1 gene (BAP1) in the development of MMe. In this study, the chemosensitivity of human mesothelioma cell lines carrying BAP1 wild-type (WT), mutant and silenced was analysed. The BAP1 mutant cells were significantly less sensitive than BAP1 WT cell lines to the clinically relevant drug gemcitabine. Silencing of BAP1 significantly increased resistance of MMe cells to gemcitabine. Cell cycle analysis suggested that gemcitabine induced Sub-G1 phase accumulation of the BAP1 WT cells and increased in the S-phase in both BAP1 WT and mutant cells. Analysis of the role of BAP1 in apoptosis suggested that gemcitabine induced early apoptosis in both BAP1 WT and BAP1 mutant cells but with a much higher degree in the WT cells. Effects on the population of cells in late apoptosis, which can mark necrosis and necroptosis, could not be seen in the mutant cells, highlighting the possibility that BAP1 plays a role in several types of cell death. Significantly decreased DNA damage in the form of double-strand breaks was observed in gemcitabine-treated BAP1 mutant cells, compared to BAP1 WT cells under the same conditions. After BAP1 silencing, a significant decrease in DNA damage in the form of double-strand breaks was observed compared to cells transfected with scramble siRNA. Taken together, the results presented in this manuscript shed light on the role of BAP1 in the response of MMe cells to gemcitabine treatment and in particular in the control of the DNA damage response, therefore providing a potential route for more efficient MMe therapy." @default.
• W2909210318 created "2019-01-25" @default.
• W2909210318 creator A5024798356 @default.
• W2909210318 creator A5027312995 @default.
• W2909210318 creator A5041042009 @default.
• W2909210318 creator A5046342583 @default.
• W2909210318 creator A5060138867 @default.
• W2909210318 creator A5080825142 @default.
• W2909210318 creator A5084519811 @default.
• W2909210318 date "2019-01-19" @default.
• W2909210318 modified "2023-09-26" @default.
• W2909210318 title "BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment" @default.
• W2909210318 cites W1863979973 @default.
• W2909210318 cites W1875395771 @default.
• W2909210318 cites W1986302429 @default.
• W2909210318 cites W1987724930 @default.
• W2909210318 cites W1995569417 @default.
• W2909210318 cites W2001459942 @default.
• W2909210318 cites W2007265317 @default.
• W2909210318 cites W2007541023 @default.
• W2909210318 cites W2011610189 @default.
• W2909210318 cites W2021816354 @default.
• W2909210318 cites W2028502518 @default.
• W2909210318 cites W2040493649 @default.
• W2909210318 cites W2050014528 @default.
• W2909210318 cites W2053125535 @default.
• W2909210318 cites W2070177764 @default.
• W2909210318 cites W2070195376 @default.
• W2909210318 cites W2071818162 @default.
• W2909210318 cites W2072355125 @default.
• W2909210318 cites W2072630073 @default.
• W2909210318 cites W2085531754 @default.
• W2909210318 cites W2090282518 @default.
• W2909210318 cites W2092892924 @default.
• W2909210318 cites W2099293633 @default.
• W2909210318 cites W2102804556 @default.
• W2909210318 cites W2117596181 @default.
• W2909210318 cites W2127015328 @default.
• W2909210318 cites W2131281949 @default.
• W2909210318 cites W2149296898 @default.
• W2909210318 cites W2151439313 @default.
• W2909210318 cites W2154152846 @default.
• W2909210318 cites W2158929973 @default.
• W2909210318 cites W2219799225 @default.
• W2909210318 cites W2261455423 @default.
• W2909210318 cites W2291531085 @default.
• W2909210318 cites W2401241209 @default.
• W2909210318 cites W2500721338 @default.
• W2909210318 cites W2517460900 @default.
• W2909210318 cites W2556189512 @default.
• W2909210318 cites W2582398921 @default.
• W2909210318 cites W2594718021 @default.
• W2909210318 cites W2621539987 @default.
• W2909210318 cites W2624817404 @default.
• W2909210318 cites W2627067328 @default.
• W2909210318 cites W2727254171 @default.
• W2909210318 cites W2728307080 @default.
• W2909210318 cites W2734271067 @default.
• W2909210318 cites W2768201638 @default.
• W2909210318 cites W2802080867 @default.
• W2909210318 cites W2896543401 @default.
• W2909210318 cites W2899300405 @default.
• W2909210318 cites W2901948004 @default.
• W2909210318 cites W4245520901 @default.
• W2909210318 cites W4296217589 @default.
• W2909210318 doi "https://doi.org/10.3390/ijms20020429" @default.
• W2909210318 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6359027" @default.
• W2909210318 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30669483" @default.
• W2909210318 hasPublicationYear "2019" @default.
• W2909210318 type Work @default.
• W2909210318 sameAs 2909210318 @default.
• W2909210318 citedByCount "38" @default.
• W2909210318 countsByYear W29092103182019 @default.
• W2909210318 countsByYear W29092103182020 @default.
• W2909210318 countsByYear W29092103182021 @default.
• W2909210318 countsByYear W29092103182022 @default.
• W2909210318 countsByYear W29092103182023 @default.
• W2909210318 crossrefType "journal-article" @default.
• W2909210318 hasAuthorship W2909210318A5024798356 @default.
• W2909210318 hasAuthorship W2909210318A5027312995 @default.
• W2909210318 hasAuthorship W2909210318A5041042009 @default.
• W2909210318 hasAuthorship W2909210318A5046342583 @default.
• W2909210318 hasAuthorship W2909210318A5060138867 @default.
• W2909210318 hasAuthorship W2909210318A5080825142 @default.
• W2909210318 hasAuthorship W2909210318A5084519811 @default.
• W2909210318 hasBestOaLocation W29092103181 @default.
• W2909210318 hasConcept C121608353 @default.
• W2909210318 hasConcept C1491633281 @default.
• W2909210318 hasConcept C153911025 @default.
• W2909210318 hasConcept C185592680 @default.
• W2909210318 hasConcept C190283241 @default.
• W2909210318 hasConcept C2776694085 @default.
• W2909210318 hasConcept C2778239845 @default.
• W2909210318 hasConcept C2780258809 @default.
• W2909210318 hasConcept C29537977 @default.
• W2909210318 hasConcept C31573885 @default.
• W2909210318 hasConcept C502942594 @default.
• W2909210318 hasConcept C54009773 @default.

• next